Mehwish Solangi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

High Resolution

Top Venues

Future medicinal chemistry

Archiv der Pharmazie

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Maqbool, Mehwish Solangi, Khalid Mohammed Khand, Musa Özil, Nimet Baltaş, Uzma Salar, Syeda S Tariq, Zaheer Ul Haq, Muhammad Taha
Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies. Archiv der Pharmazie 357 (9) (2024)
Maryam Maqbool, Mehwish Solangi, Khalid Mohammed Khand, Musa Özil, Nimet Baltaş, Uzma Salar, Syeda S Tariq, Zaheer Ul Haq, Muhammad Taha
Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies. Archiv der Pharmazie (2024)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Faiza Saleem, Fariha Shamim, Musa Özil, Nimet Baltaş, Uzma Salar, Sajda Ashraf, Zaheer Ul Haq, Muhammad Taha, Mehwish Solangi, Khalid Mohammed Khand
Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors. Future medicinal chemistry (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Mehwish Solangi, Khalid Mohammed Khand, Xingyue Ji, Musa Özil, Nimet Baltaş, Uzma Salar, Alamgir Khan, Zaheer Ul Haq, Herchand Meghwar, Muhammad Taha
Indole-pyridine carbonitriles: multicomponent reaction synthesis and bio-evaluation as potential hits against diabetes mellitus. Future medicinal chemistry (2023)
Ayaz Ahmed, Anum Khalid Khan, Aneela Karim, Rakhshinda Siddiqui, Rafaila Rafique, Syed Abid Ali, Mehwish Solangi, Muhammad Taha, Khalid Mohammed Khand
Enoxacin-based derivatives: antimicrobial and antibiofilm agent: a biology-oriented drug synthesis (BIODS) approach. Future medicinal chemistry 14 (13) (2022)
Syed Muhammad Umer, Mehwish Solangi, Khalid Mohammed Khan, Rahman Shah Zaib Saleem
Indole-Containing Natural Products 2019-2022: Isolations, Reappraisals, Syntheses, and Biological Activities. Molecules (Basel, Switzerland) 27 (21) (2022)
Shehryar Hameed, Oluwatoyin Babatunde, Uzma Salar, Abdul Jabbar, Sridevi Chigurupati, Mehwish Solangi, Lubna Atta, Zaheer Ul Haq, Faiza Saleem, Saurabh Bhatia, Ahmed Al-Harrasi, Muhammad Taha, Khalid Mohammed Khand
Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer's disease. Future medicinal chemistry 14 (21) (2022)
Mehwish Solangi, null Kanwal, Khalid Mohammed Khand, Sridevi Chigurupati, Faiza Saleem, Urooj Qureshi, Zaheer Ul-Haq, Almas Jabeen, Shatha G Felemban, Fatima Zafar, Shahnaz Perveen, Muhammad Taha, Saurabh Bhatia
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies. Archiv der Pharmazie 355 (6) (2022)